Skip to content

Prevention of Parastomal Hernia by Mesh Placement

A Randomized Study of the Utility of Composite Mesh Placement to Prevent Parastomal Hernia in Patients Undergoing Urinary Diversion With Ileal Conduit

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02404545
Enrollment
12
Registered
2015-03-31
Start date
2015-08-14
Completion date
2017-03-31
Last updated
2017-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parastomal Hernia

Keywords

Hernia, Mesh, Ileal conduit

Brief summary

Concurrent placement of a mesh during formation of ileal conduit will decrease the incidence of parastomal hernia and associated complications.

Detailed description

Subject to inclusion and exclusion criteria, patients will be randomized 1:1 to the control and intervention groups: Randomization groups: * Group 1 (control): Ileal Conduit * Group 2 (intervention): Ileal conduit with concurrent mesh placement. Ethicon PHYSIOMESH composite mesh will be utilized for this study. This is a composite mesh with a reduced polypropylene content. It is a widely used, commercially available hernia mesh, and its use and placement are simple and well described. The mesh will be placed at the time of radical cystectomy and ileal conduit. A small circle of mesh, the diameter of the ileal conduit, will be excised to allow for fitment around the ileal conduit. The mesh will be placed so that it encompasses the ileal conduit in a non-constricting manner, and will be sutured to the anterior abdominal wall. Product will be stored in a secure, sterile manner at the UMH operating room sterile supply room, and in accordance with institutional policies. Patients from both groups will be followed up in a standard fashion. Follow up visits and clinical assessment will be at 6 weeks after surgery, 3 monthly during the first year, then every 6 months for at least 5 years. During each visit, patients will be clinically evaluated for the presence or absence of parastomal hernia, and any routine surveillance radiology imaging will be reviewed. Parastomal hernia is clinically defined as an incisional hernia at the site of the ileal conduit stoma. This may be clinically apparent by examining the patient during performance of abdominal straining or Valsalva maneuver, or may be evident on radiology imaging.

Interventions

DEVICEEthicon Physiomesh

Ethicon Physiomesh will be paced at the time of radical cystectomy and ileal conduit.

Sponsors

Ethicon, Inc.
CollaboratorINDUSTRY
University of Miami
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Patients eligible to undergo urinary diversion with ileal conduit. 2. Patients with the ability to understand and willingness to sign a written informed consent document. 3. Men and Women aged 18 to 80 years.

Exclusion criteria

1. Patients unable or unwilling to consent to the proposed surgery 2. Pregnant women 3. Patients with prior ileal conduit surgery undergoing revision.

Design outcomes

Primary

MeasureTime frameDescription
Rate of Reduction of the Incidence of Parastomal Hernia18 monthsRate of reduction of the incidence of parastomal hernia in study participants, as assessed by physical examination

Secondary

MeasureTime frameDescription
Number of Participants Who Develop Mesh Related Complications60 monthsAssessed by physical examination including: * Mesh erosion and infection * Stomal stenosis and necrosis * Frequency of stoma pouch appliance changes. * Record by physical exam the incidence of parastomal hernia at 5 years.

Countries

United States

Participant flow

Participants by arm

ArmCount
Group 1 - Ideal Conduit No Mesh
No mesh will be placed at the time of radical cystectomy and ileal conduit.
6
Group 2 - Ileal Conduit With Mesh
Ethicon Physiomesh will be placed at the time of radical cystectomy and ileal conduit. Ethicon Physiomesh: Ethicon Physiomesh will be paced at the time of radical cystectomy and ileal conduit.
6
Total12

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudySponsor Termination66

Baseline characteristics

CharacteristicGroup 1 - Ideal Conduit No MeshGroup 2 - Ileal Conduit With MeshTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
5 Participants3 Participants8 Participants
Age, Categorical
Between 18 and 65 years
1 Participants3 Participants4 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants2 Participants4 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
4 Participants4 Participants8 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
1 Participants1 Participants2 Participants
Race (NIH/OMB)
More than one race
0 Participants1 Participants1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
5 Participants4 Participants9 Participants
Region of Enrollment
United States
6 Participants6 Participants12 Participants
Sex: Female, Male
Female
2 Participants1 Participants3 Participants
Sex: Female, Male
Male
4 Participants5 Participants9 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 60 / 6
other
Total, other adverse events
0 / 60 / 6
serious
Total, serious adverse events
0 / 60 / 6

Outcome results

Primary

Rate of Reduction of the Incidence of Parastomal Hernia

Rate of reduction of the incidence of parastomal hernia in study participants, as assessed by physical examination

Time frame: 18 months

Population: The study required a minimum of 13 participants enrolled per arm for analysis of this outcome measure. Due to the manufacturer's (Ethicon) termination of the Physiomesh device, the study was prematurely terminated with fewer than minimum number of participants required on each arm, and the data were not analyzed.

Secondary

Number of Participants Who Develop Mesh Related Complications

Assessed by physical examination including: * Mesh erosion and infection * Stomal stenosis and necrosis * Frequency of stoma pouch appliance changes. * Record by physical exam the incidence of parastomal hernia at 5 years.

Time frame: 60 months

Population: The study required a minimum of 13 participants enrolled per arm for analysis of this outcome measure. Due to the manufacturer's (Ethicon) termination of the Physiomesh device, the study was prematurely terminated with fewer than minimum number of participants required on each arm, and the data were not analyzed.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026